Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Perrigo and Tris Pharma have together launched a major new store brand version of Delsym, an extended-release oral liquid suspension.
Subscribe to our email newsletter
Delsym containing dextromethorphan polistirex is used for the treatment for cough due to minor throat and bronchial irritation.
Perrigo chairman, president and CEO Joseph Papa said, "We are excited to partner with Tris Pharma and bring this first ever store brand extended release liquid cough/cold product to our retail and store brand customers’ portfolios in time for the season."
Tris CEO Ketan Mehta said when the company developed its proprietary technology to deliver drugs in taste-neutral, extended release dosage forms such as liquids and ODT/chewable tablets, it focused on improving the profile of new drugs.
"However, Delsym presented a unique opportunity where we were able to leverage our technology to bring a long overdue lower cost alternative to consumers and I am delighted we were able to partner with Perrigo to do so," Mehta added.